Тёмный

Dupilumab for COPD | NEJM 

NEJM Group
Подписаться 161 тыс.
Просмотров 8 тыс.
50% 1

Some patients with COPD have type 2 inflammation, which may increase exacerbation risk. Dupilumab, a monoclonal antibody, targets type 2 inflammatory cytokines.
New research findings are summarized in a short video.
To see the full article, follow this link: nej.md/3Mkskdy

Опубликовано:

 

14 окт 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 9   
@kimoco
@kimoco Год назад
This drug gave me my life back. I hope they publish and peer review and FDA approve ASAP so more can access this drug.
@aujax1
@aujax1 9 месяцев назад
what did you take it for? copd?
@ThaMoonwalkerFSDBetaChannel
@ThaMoonwalkerFSDBetaChannel 6 месяцев назад
Did you take itnfor COPD
@kimoco
@kimoco 6 месяцев назад
@@aujax1 yes,
@kimoco
@kimoco 6 месяцев назад
@@ThaMoonwalkerFSDBetaChannel yes
@ChuckKarges
@ChuckKarges 7 месяцев назад
Im trying to get this the inhalers dont really work always short of breath had to walk on tregey ike ti know if the pill help anybody go see s doc 2 weeks for valves but borderline hoping something goves day to day sucks
@wellbodisalone
@wellbodisalone 11 месяцев назад
Great video!
@notarjunupadhyaya1190
@notarjunupadhyaya1190 Год назад
Thank you very much ❤️
@dharghamalturaihi3511
@dharghamalturaihi3511 Год назад
Exciting, amazing
Далее
Finally! How Ketosis Really Works.
7:48
Просмотров 38 тыс.
Dupixent
23:17
Просмотров 25 тыс.
Treating Uncontrolled Asthma
2:23
Просмотров 8 тыс.
New procedure giving COPD patients hope, relief
2:56
Bayesian Way | NEJM Evidence
6:20
Просмотров 8 тыс.
GOLD 2024 COPD Guidelines: What's New in It ?
27:52
Просмотров 16 тыс.
Reducing Exacerbations in COPD
2:04
Просмотров 13 тыс.